Navigation Links
Exiqon: Major Shareholder Announcement
Date:6/30/2008

VEDBAEK, Denmark, June 30 /PRNewswire-FirstCall/ -- Exiqon A/S today received information from Danske Bank, that the Danske Bank Group - including Danica Pension Livsforsikring and Danske Fund FCP - through acquisition today of 502,300 shares now owns 1,804,514 shares of a nominal value of each DKK 1 corresponding to 5,99% of the share capital and 5,99% of the voting rights in Exiqon A/S.

About Exiqon

Exiqon's corporate mission is to combine leading-edge scientific expertise in gene expression with our proprietary LNA(TM) technology. Exiqon's products, services and scientific staff enable life science researchers to make groundbreaking discoveries. Moreover, Exiqon is addressing the unmet need for a new approach to the diagnosis of cancer. Exiqon's products are based on patented technology (LNA(TM) or Locked Nucleic Acids) that facilitates very precise and sensitive analysis of nucleic acids. Exiqon aims to expand the existing product offering for research use as well as to develop new proprietary molecular diagnostic products. Exiqon, through a number of recent initiatives, has positioned itself as a significant player in applying miRNA as the key biomarker in cancer diagnostics. Exiqon has facilities in Denmark, Boston (MA) and Tustin (CA).

For more information, please contact:

Exiqon A/S,

Lars Kongsbak, President and CEO, tel. +45-40-90-21-01,

Hans Henrik Chrois Christensen, CFO, tel. +45-40-90-2131.


'/>"/>
SOURCE Exiqon
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Palladian Muscular Skeletal Health (formerly Prism Health Networks) to Promote Collaborative, Expanded Practice Model at Major Insurance Conference in June
2. Cord Blood America Reports CorCell, Its Major Acquisition in 2006, Turns Profitable
3. BioElectronics Corporation Receives Major Orders From Italian Distributor
4. deCODE Discovers Fourth Major Set of Common Genetic Variants Linked to Risk of Estrogen Receptor-Positive Breast Cancer
5. Syngenta To Build Major Global Biotech Research Center in Beijing, China
6. Axial Biotech Meets Major Scientific Milestones; Receives $6 Million Tranche of Series B Financing
7. Major EPA enforcement effort on nano-pesticide applauded
8. Cardiac Science Unveils Major Brand Change; Strategy to Lift Brand Awareness
9. Major Medical Journal Reports Higher Success, Fewer Complications and Lower Cost Treating DVT With Trellis(R) Isolated Thrombolysis Compared With Catheter-Directed Thrombolysis
10. FDA Approves PRISTIQ(TM) for the Treatment of Adult Patients with Major Depressive Disorder
11. AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Major Depressive Disorder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... Hong Kong (PRWEB) , ... May 22, 2017 ... ... the third year in a row in the Aragon Research Globe™ for Corporate ... that align with industry direction and market demand, and effectively perform against those ...
(Date:5/23/2017)... (PRWEB) , ... May 23, 2017 , ... ... Works as Vice President of Clinical Operations. She brings years of expertise ... Yaupon Therapeutics. From her professional foundation as a licensed occupational therapist, through a ...
(Date:5/22/2017)... (PRWEB) , ... May 22, 2017 , ... Stratevi, a ... expanded to the East Coast. It has opened an office in downtown Boston at ... are finding it increasingly more important to generate evidence on the value they provide, ...
(Date:5/21/2017)... ... May 20, 2017 , ... ... the lengthy trial and error process by finding the right antidepressant faster. ... strengthen the doctor-patient relationship through a personalized approach to treatment. , ...
Breaking Biology Technology:
(Date:4/17/2017)... , April 17, 2017 NXT-ID, Inc. (NASDAQ: ... announces the filing of its 2016 Annual Report on Form 10-K ... Commission. ... 10-K is available in the Investor Relations section of the Company,s ... the SEC,s website at http://www.sec.gov . 2016 Year ...
(Date:4/11/2017)... 11, 2017 Crossmatch®, a globally-recognized leader ... today announced that it has been awarded a ... Activity (IARPA) to develop next-generation Presentation Attack Detection ... "Innovation has been a driving force within Crossmatch ... allow us to innovate and develop new technologies ...
(Date:4/11/2017)... NXT-ID, Inc. (NASDAQ:   NXTD ) ("NXT-ID" or ... independent Directors Mr. Robin D. Richards and Mr. ... the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive Officer said," ... and benefiting from their considerable expertise as we move forward ...
Breaking Biology News(10 mins):